Donor HO-1 expression inhibits intimai hyperplasia in unmanipulated graft recipients: A potential role for CD8+ T-cell modulation by carbon monoxide

Transplantation

Volumn 88, Issue 5, 2009, Pages 653-661

  Clarke, Helen M ^a   Shrivastava, Seema ^a   Motterlini, Roberto ^b,c   Sawle, Philip ^b   Chen, Daxin ^a   Dorling, Anthony ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Endothelium; Heme oxygenase; Interferon gamma; Intimal hyperplasia; T cell

Indexed keywords

CARBON MONOXIDE; GAMMA INTERFERON; HEME OXYGENASE 1; HEMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DONOR; ENDOTHELIUM CELL; GRAFT RECIPIENT; IMMUNOMODULATION; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; AORTA; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; FEMALE; HYPERPLASIA; METABOLISM; METHODOLOGY; REPERFUSION INJURY; TRANSPLANTATION;

ANIMALS; AORTA; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; ENDOTHELIAL CELLS; FEMALE; HEME OXYGENASE-1; HYPERPLASIA; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REPERFUSION INJURY; TRANSPLANTATION;

EID: 70349567379     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b2fd83     Document Type: Article

References (63)

1. Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 2005; 352: 1371. (Pubitemid 40411505)
2. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387.
3. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003; 9: 22.
4. Warren DS, Zachary AA, Sonnenday CJ, et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004; 4: 561.
5. Piatt JL, Fischel RJ, Matas AJ, et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
6. 6. Lin Y, Soares MP, Sato K, et al. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. J Immunol 1999; 163: 2850. (Pubitemid 29399215)
7. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196.
8. Salama AD, Delikouras A, Pusey CD, et al. Transplant accommodation in highly sensitized patients: A potential role for Bcl-xL and alloantibody. Am J Transplant 2001; 1: 260. (Pubitemid 33674170)
9. Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4: 1073. (Pubitemid 28417343)
10. Almolki A, Taille C, Martin GF, et al. Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol 2004; 287: L26. (Pubitemid 38787647)
11. Yet SF, Tian R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89: 168. (Pubitemid 34135825)
12. Otterbein L, Sylvester SL, Choi AM. Hemoglobin provides protection against lethal endotoxemia in rats: The role of heme oxygenase- 1. Am J Respir Cell Mol Biol 1995; 13: 595.
13. Braudeau C, Bouchet D, Tesson L, et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004; 11: 701. (Pubitemid 38519278)
14. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation 2002; 74: 905. (Pubitemid 35191234)
15. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183. (Pubitemid 36227720)
16. Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172: 4744.
17. McDaid J, Yamashita K, Chora A, et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J 2005; 19: 458. (Pubitemid 40316549)
18. Choi BM, Pae HO, Jeong YR, et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327: 1066.
19. Yamashita K, Ollinger R, McDaid J, et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 2006; 20: 776. (Pubitemid 46671212)
20. 20. Zelenay S, Chora A, Soares MP, et al. Heme oxygenase-1 is not required for mouse regulatory T cell development and function, Int Immunol 2007; 19: 11. (Pubitemid 46017883)
21. 21. Chow LH, Huh S, Jiang J, et al. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 1996; 94: 3079. (Pubitemid 26427469)
22. Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93: e2.
23. 23. Dambrin C, Calise D, Pieraggi MT, et al. Orthotopic aortic transplantation in mice: A new model of allograft arteriosclerosis. J Heart Lung Transplant 1999; 18: 946. (Pubitemid 29505482)
24. 24. Marelli-Berg FM, Peek E, Lidington EA, et al. Isolation of endothelial cells from murine tissue. J Immunol Methods 2000; 244: 205. (Pubitemid 30734229)
25. 25. Chen D, Giannopoulos K, Shiels PG, et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood 2004; 104: 1344. (Pubitemid 39166509)
26. 26. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 77. (Pubitemid 29096240)
27. 27. Delikouras A, Hayes M, Malde P, et al. Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factoralpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 2001; 71: 599. (Pubitemid 32268057)
28. 28. Motterlini R, Foresti R, Intaglietta M, et al. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996; 270 (1 pt 2): H107. (Pubitemid 126756063)
29. 29. Balogun E, Hoque M, Gong P, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biodiem J 2003; 371 (pt 3): 887. (Pubitemid 36578887)
30. 30. Liu J, Liu Z, Witkowski P, et al. Rat CD8 + FOXP3 + T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 2004; 13: 239. (Pubitemid 39602590)
31. Manavalan JS, Kim-Schulze S, Scotto L, et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004; 16: 1055.
32. 32. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim Biophys Acta 1996; 1317: 65. (Pubitemid 26336596)
33. Yamashita K, McDaid J, Ollinger R, et al. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 2004; 18: 765.
34. 34. Motterlini R, Mann BE, Johnson TR, et al. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 2003; 9: 2525. (Pubitemid 37236371)
35. 35. Ensminger SM, Spriewald BM, Witzke O, et al. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation 2002; 73: 1068. (Pubitemid 34415436)
36. 36. Soleimani B, Katopodis A, Wieczorek G, et al. Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimai hyperplasia. Clin Exp Immunol 2006; 146: 509. (Pubitemid 44722171)
37. 37. Ensminger SM, Spriewald BM, Witzke O, et al. Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation 2002; 73: 279. (Pubitemid 34112854)
38. 38. Fischbein MP, Ardehali A, Yun J, et al. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 2000; 165: 7316. (Pubitemid 32001212)
39. Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.
40. Cuffy MC, Silverio AM, Qin L, et al. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege.J Immunol 2007; 179: 5246.
41. 41. Ensminger SM, Witzke O, Spriewald BM, et al. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000; 69: 2609. (Pubitemid 30482029)
42. 42. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403: 207. (Pubitemid 30050965)
43. Musameh MD, Green CJ, Mann BE, et al. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3). J Heart Lung Transplant 2007; 26: 1192.
44. Bagul A, Hosgood SA, Kaushik M, et al. Carbon monoxide protects against, ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation 2008; 85: 576.
45. Han JW, Shimada K, Ma-Krupa W, et al. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res 2008; 102: 546.
46. 46. Chauveau C, Remy S, Royer PJ, et al. Heme oxygenase-1 expression inhibits dendritic cell, maturation and proinflammatory function but conserves IL-10 expression. Blood 2005; 106: 1694. (Pubitemid 41208583)
47. 47. Listopad J, Asadullah K, Sievers C, et al. Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 2007; 16: 661. (Pubitemid 47079596)
48. 48. Thebault P, Condamine T, Heslan M, et al. Role of IFNgamma in allograft tolerance mediated by CD4(+)CD25( + ) regulatory T cells by induction of IDO in endothelial cells. Am J Transplant 2007; 7: 2472. (Pubitemid 47561604)
49. 49. Cobbold SP, Adams E, Graca L, et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev 2006; 213: 239. (Pubitemid 44401505)
50. Fischbein MP, Yun J, Laks H, et al. CD8+ lymphocytes augment chronic rejection in a MHC class Il mismatched model. Transplantation 2001; 71: 1146. (Pubitemid 32448833)
51. Fischbein MP, Yun J, Laks H, et al. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2002; 123: 803. (Pubitemid 34535092)
52. Wang Y, Burns WR, Tang PC, et al. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J 2004; 18: 606.
53. Koksoy S, Kakoulidis TP, Shirwan H. Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-gamma and IL-10 producing T cells. Transpl Immunol 2004; 13: 201. (Pubitemid 39285977)
54. Hayashi M, Martinez OM, Garcia-Kennedy R, et al. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 1995; 60: 1533. (Pubitemid 26012689)
55. Obata F, Yoshida K, Ohkubo M, et al. Contribution of CD4+ and CD8+ T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: The Th1 response mediates both acute and chronic rejection. Transpl Immunol 2005; 14: 21. (Pubitemid 40462285)
56. Hagemeijer MC, van Oosterhout MF, van Wichen DF, et al. T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population. Am J Transplant 2008; 8: 1040.
57. Song R, Mahidhara RS, Zhou Z, et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172:1220. (Pubitemid 38113785)
58. Neto JS, Nakao A, Toyokawa H, et al. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Am J Physiol Renal Physiol 2006; 290: F324. (Pubitemid 43738984)
59. Tsui TY, Wu X, Lau CK, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623. (Pubitemid 36628946)
60. Tullius SG, Nieminen-Kelha M, Buelow R, et al. Inhibition of ischemia/ reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74: 591.
61. 61. Skaro AI, Liwski RS, O'Neill J, et al. Impairment of recipient cytolytic activity attenuates allograft vasculopathy. Transpl Immunol 2005; 14: 27. (Pubitemid 40462286)
62. 62. Skaro AI, Liwski RS, Zhou J, et al. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Cardiovasc Res 2005; 65: 283. (Pubitemid 40038502)
63. Vessie EL, Hirsch GM, Lee TD. Aortic allograft vasculopathy is mediated by CD8( + ) T cells in Cyclosporin A immunosuppressed mice. Transpl Immunol 2005; 15: 35.